Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14.

Saved in:
Bibliographic Details
Title: Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14.
Authors: Nakamoto S; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan., Kajiwara Y; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.; Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan., Taniguchi K; Department of Pathology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan., Hida AI; Department of Pathology, Matsuyama Shimin Hospital, Matsuyama, Japan., Miyoshi Y; Department of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan.; Department of Breast Endocrine Surgery, Kagawa Prefectural Center Hospital, Takamatsu, Japan., Kin T; Department of Breast Surgery, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan., Yamamoto M; Department of Breast and Thyroid Surgery, Fukuyama City Hospital, Fukuyama, Japan.; Department of Breast and Thyroid Surgery, Onomichi Municipal Hospital, Onomichi, Japan., Takabatake D; Department of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan.; Department of Breast and Thyroid Surgery, Kochi Health Science Center, Kochi, Japan., Kubo S; Department of Breast and Thyroid Surgery, Fukuyama City Hospital, Fukuyama, Japan., Hikino H; Department of Breast Surgery, Matsue Red Cross Hospital, Matsue, Japan., Ogasawara Y; Department of Breast Endocrine Surgery, Kagawa Prefectural Center Hospital, Takamatsu, Japan., Ikeda M; Department of Breast and Thyroid Surgery, Fukuyama City Hospital, Fukuyama, Japan., Doihara H; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.; Department of General Surgery, Kawasaki Medical School General Medical Center, Okayama, Japan., Shien T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan., Taira N; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.; Department of Breast and Thyroid Surgery, Kawasaki Medical School Hospital, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan., Iwamoto T; Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan. tiwamoto@med.kawasaki-m.ac.jp.; Department of Breast and Thyroid Surgery, Kawasaki Medical School Hospital, 577 Matsushima, Kurashiki, Okayama, 701-0192, Japan. tiwamoto@med.kawasaki-m.ac.jp., Toyooka S; Department of General Thoracic Surgery and Breast and Endocrinological Surgery, Graduate School of Medicine Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Nov; Vol. 208 (1), pp. 67-77. Date of Electronic Publication: 2024 Jun 18.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1573-7217
DOI:10.1007/s10549-024-07395-7